RE: BionTech / Scancell Deal6 Oct 2019 20:55
Chester, lets hope you are right and I will mention again for the plans we have, it seems the BOD are confident too of tying up a commercial deal early next year, as they sounded just before the Vulpes deal this year.
I just cannot see how we are funded for the MOD1 trial, but funded until early 2021 if that is not the case.
Can only agree the next few months as ever will be key on all fronts, and rather the odd spike or two to me I am holding, so would prefer to see a solid rerate based on getting closer to the prizes on offer.
News on dosing the first patient cannot be far off, the first patient was recruited August 19th, and the criteria for admission to trial (just one of many) was to have a life expectancy exceeding three months. It not only reminds us how ill these patients are, but for that first patient alone we are nearing two months since recruitment and it is a matter of urgency they be dosed accordingly as soon as. We just don"t know what the update will cover or when, I rather hope it will be all patients recruited and immune responses confirmed. News appertaining to possible deals can hit us anytime in the coming months before year end.
A bit off topic, but got a lot of pleasure watching Chelsea today, I have no expectations this year, in two years I do, but their progress is for all to see and it excites me. To a good week ahead, was surprised to see us fall to 6.50/7 last week after such large buys and sells, 2.3m buys last week buys in a day at 7,25, and we fall. Again we need news that will bring back the buyers, which PI wise have been missing for many weeks.
So fingers crossed for a good week and a welcome return to some very on topic posts. Goodnight.